Royal College of Surgeons in Ireland, Dublin 2, Ireland.
Ir J Med Sci. 2011 Jun;180(2):475-8. doi: 10.1007/s11845-011-0683-7. Epub 2011 Feb 3.
There have been reports of thalidomide-affected people suffering a deterioration in their disability over time [1, 2]. This study assessed changes in disabilities among thalidomide-affected people in the Irish population.
A questionnaire, assessing musculo-skeletal health, quality-of-life, general health and illness intrusiveness was sent to 26 people affected by thalidomide in the Republic of Ireland.
Seventeen (65%) responded. Six (35%) respondents were not working as a result of their disability. Eleven (65%) reported a worsening of their disability over time, with nine of them reporting the deterioration as moderate to severe. The impact of this decline was measured by respondents in terms of ability to perform daily tasks, emotional health and finances (due to extra costs related to clothing, transport, housing alterations and heating).
There is a need to continually review the physical, psychological and social needs of thalidomide survivors in order to ensure optimum care is made available.
有报道称,沙利度胺受影响者的残疾状况随时间恶化[1,2]。本研究评估了爱尔兰人口中沙利度胺受影响者残疾状况的变化。
向 26 名在爱尔兰共和国受沙利度胺影响的人发送了一份评估肌肉骨骼健康、生活质量、一般健康和疾病侵扰的问卷。
17 人(65%)做出了回应。6 人(35%)因残疾而无法工作。11 人(65%)报告残疾状况随时间恶化,其中 9 人报告恶化程度为中度至重度。这种下降的影响是由受访者根据完成日常任务、情绪健康和财务状况(由于与服装、交通、住房改造和供暖相关的额外费用)来衡量的。
需要不断审查沙利度胺幸存者的身体、心理和社会需求,以确保提供最佳护理。